This is an open-label extension study offered only to those who have been part of the NO-PARK trial. The primary objective of this study is to monitor NR use for long term safety. The secondary objective is to monitor long term NR use among PD patients and observe the clinical progression of PD.

More info: Clinical Trial on Safety Issues: Nicotinamide Riboside – Clinical Trials Registry – ICH GCP 

Contact: Head Research Nurse Erika V. Sheard: +47 992 04 028, erika.veslemoy.sheard@helse-bergen.no